Brokerages Set Anteris Technologies Global Corp. (NASDAQ:AVR) Price Target at $16.50

Anteris Technologies Global Corp. (NASDAQ:AVRGet Free Report) has earned an average recommendation of “Moderate Buy” from the five research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $16.50.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Anteris Technologies Global in a report on Tuesday.

Get Our Latest Analysis on AVR

Hedge Funds Weigh In On Anteris Technologies Global

Institutional investors and hedge funds have recently bought and sold shares of the company. Russell Investments Group Ltd. lifted its holdings in shares of Anteris Technologies Global by 76.9% during the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after purchasing an additional 2,841 shares during the last quarter. Corebridge Financial Inc. acquired a new position in Anteris Technologies Global during the 1st quarter valued at about $27,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Anteris Technologies Global in the first quarter valued at about $32,000. BNP Paribas Financial Markets raised its stake in Anteris Technologies Global by 83.3% in the third quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock valued at $43,000 after buying an additional 4,302 shares during the last quarter. Finally, Bank of America Corp DE boosted its holdings in Anteris Technologies Global by 35.7% in the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after acquiring an additional 2,798 shares in the last quarter.

Anteris Technologies Global Trading Down 1.7%

Shares of NASDAQ:AVR opened at $4.10 on Friday. The company has a market capitalization of $168.92 million and a PE ratio of -2.27. The company has a current ratio of 0.84, a quick ratio of 0.80 and a debt-to-equity ratio of 0.01. Anteris Technologies Global has a 12-month low of $2.34 and a 12-month high of $8.79. The business’s fifty day simple moving average is $4.41 and its 200-day simple moving average is $4.15.

Anteris Technologies Global (NASDAQ:AVRGet Free Report) last issued its quarterly earnings data on Wednesday, November 12th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.05). Anteris Technologies Global had a negative return on equity of 252.71% and a negative net margin of 3,944.93%.The company had revenue of $0.43 million for the quarter, compared to analysts’ expectations of $0.74 million. As a group, equities research analysts predict that Anteris Technologies Global will post -2.66 earnings per share for the current fiscal year.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Featured Stories

Analyst Recommendations for Anteris Technologies Global (NASDAQ:AVR)

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.